THENATIONALPULSE (Pulse Wires) - After Initial Rejection, FDA Greenlights First mRNA Flu Vaccine.
The Food and Drug Administration (FDA) has approved Moderna's mRNA-based seasonal flu vaccine.
The Food and Drug Administration (FDA) has granted approval for Moderna’s mRNA-based flu vaccine for adults 50 and older, despite earlier regulatory concerns. PULSE POINTS WHAT HAPPENED: The Food and Drug Administration (FDA) has approved Moderna’s mRNA-based seasonal flu vaccine . DETAIL: Named mFLUSIVA, the vaccine was approved on Wednesday. It is aimed at people aged 50 and older. The decision comes after the FDA initially declined to approve the vaccine back in February. Specifically, the vaccine was initially blocked as the clinical trial did not use the best available comparator for adults aged 65 and older. “We are grateful to the clinical trial participants, investigators, regulators and Moderna teams whose…Open